Viewing Study NCT05144061


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2025-12-31 @ 4:43 PM
Study NCT ID: NCT05144061
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2021-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module